Peanut Allergy
Research Study

Researchers at Lurie Children's Hospital of Chicago and Alliance are partnering with people allergic to peanuts to investigate a potential treatment. Join our compensated study today!

Fast Facts

18-25 Years Old

peanut allergy

no previous peanut oral immunotherapy in past year

Compensation up to $665 Provided

conducted in Chicago, IL

Study Background

Researchers from the Alliance Allergy Study are conducting a research study to evaluate the safety and tolerability of a peanut oral immunotherapy.

Food allergies affect around 5 to 10% of individuals throughout the world. They happen when the immune system does not accept certain proteins in some foods. Peanut allergy is one of the most common food allergies in children. It usually starts
when individuals are very young, and then, for many, it stays even into adult life. Currently, the main way to manage peanut allergy is by being very careful to stay away from peanuts or by using emergency medicine. 

This study is testing a study drug for individuals with peanut allergy.  Pharmaceutical companies use clinical research studies like this one to learn more about study drugs before they are made available to the public.

Further research today and join our compensated study!

Additional Information

The purpose of this study is to evaluate an immunotherapy drug that is taken once a day as a tablet. The study drug is a tablet containing peanut protein that dissolves under the tongue. We are doing this study to find out which starting dose to use and how the rise in dose should be done in the safest possible way in adults, teenagers and children. This is so that we can find the best dose of the study drug.

You may qualify for this study if you meet the following criteria:

Key Criteria:

  • Between 18-25 years old
  • Documented history of a peanut allergy
  • No previous peanut oral immunotherapy within the last year
  • No history of eosinophilic esophagitis (EoE) 
  • No history of uncontrolled asthma
  • No history of mouth sores, lesions, or inflammation
  • No history of cardiovascular disease

Once enrolled, this study involves:

  • Participating in five in-person visits
  • Undergoing food challenges, labs, and skin prick testing
  • Completing four scheduled telephone follow-ups

Compensation is provided up to $665 for your time.

There is no cost for you to participate.